Form 8-K - Current report:
SEC Accession No. 0001628280-25-050163
Filing Date
2025-11-06
Accepted
2025-11-06 16:08:31
Documents
17
Period of Report
2025-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blfs-20251106.htm   iXBRL 8-K 25390
2 EX-99.1 q32025earningsrelease.htm EX-99.1 552524
6 GRAPHIC address-blockx3.jpg GRAPHIC 54124
7 GRAPHIC blfs_symbol.jpg GRAPHIC 19612
8 GRAPHIC logo.jpg GRAPHIC 42308
9 GRAPHIC preserve-thexpromise.jpg GRAPHIC 30637
  Complete submission text file 0001628280-25-050163.txt   923667

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blfs-20251106.xsd EX-101.SCH 1809
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blfs-20251106_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blfs-20251106_pre.xml EX-101.PRE 12526
20 EXTRACTED XBRL INSTANCE DOCUMENT blfs-20251106_htm.xml XML 2810
Mailing Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021
Business Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021 4254011400
BIOLIFE SOLUTIONS INC (Filer) CIK: 0000834365 (see all company filings)

EIN.: 943076866 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36362 | Film No.: 251458278
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)